Tectonic Therapeutic, Inc.(TECX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TECX Tectonic Therapeutic, Inc.

Pre-Mkt 08-27 04:34:21 EDT

35.97

-1.74

-4.61%

High38.85	Low35.76	Vol145.17K
Open37.41	D1 Closing37.71	Amplitude8.19%
Mkt Cap703.19M	Tradable Cap438.81M	Total Shares19.55M
T/O5.26M	T/O Rate1.19%	Tradable Shares12.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TECX","market":"US","secType":"STK","nameCN":"Tectonic Therapeutic, Inc.","latestPrice":35.97,"timestamp":1787774400000,"preClose":37.71,"halted":0,"volume":145166,"delay":0,"changeRate":-0.046141607000795594,"floatShares":12199392,"shares":19549366,"eps":-4.56781,"marketStatus":"Pre-Mkt","change":-1.74,"latestTime":"08-27 04:34:21 EDT","open":37.41,"high":38.8499,"low":35.76,"amount":5255043.023677999,"amplitude":0.081938,"askPrice":40,"askSize":1,"bidPrice":31.1,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.56781,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787837400000},"marketStatusCode":1,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":35.97,"postHourTrading":{"tag":"盘后","latestPrice":35.97,"preClose":35.97,"latestTime":"19:30 EDT","volume":1870,"amount":67311.55,"timestamp":1787787001581,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7623303780032824,"impliedVol":1.1405,"impliedVolPercentile":0.58},"requestUrl":"/m/hq/s/TECX","defaultTab":"news","newsList":[{"id":"2662744799","title":"Tectonic Therapeutic CSO Peter McNamara Disposes of USD 1,570.36 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744799","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744799?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:32","pubTimestamp":1787776327,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic CSO Peter McNamara disposes of USD 1,570.36 in common sharesPeter McNamara, chief scientific officer at Tectonic Therapeutic, exercised options for 43 shares at USD 14.71 on Aug. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL5V9QVx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tectonic Therapeutic CSO Peter McNamara Disposes of USD 1,570.36 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659212295","title":"Tectonic Therapeutic CSO Peter McNamara Reports TECX Common Share Disposal Worth $1,505 on Aug. 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2659212295","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659212295?lang=en_us&edition=fundamental","pubTime":"2026-08-15 07:26","pubTimestamp":1786749986,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic CSO Peter McNamara reports TECX common share disposal worth $1,505 on Aug. 12Tectonic Therapeutic Chief Scientific Officer Peter McNamara exercised stock options for 43 shares at ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4fpjDy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tectonic Therapeutic CSO Peter McNamara Reports TECX Common Share Disposal Worth $1,505 on Aug. 12","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658352649","title":"Truist Financial Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658352649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658352649?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:55","pubTimestamp":1786362931,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Danielle Brill maintained a Buy rating on Tectonic Therapeutic today and set a price target of $60.00. Brill covers the He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657647529","title":"Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657647529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657647529?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:28","pubTimestamp":1786116507,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Tectonic Therapeutic today and set a price target of $76.00. According to TipRanks,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661806","title":"Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661806","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661806?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:44","pubTimestamp":1786052685,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.18) per share which beat the analyst consensus estimate of $(1.37) by 13.87 percent. This is a 10.28 percent decrease over losses of $(1.07) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61026199/tectonic-therapeutic-q2-eps-1-18-beats-1-37-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663120","title":"Tectonic Therapeutic Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663120","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663120?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:57","pubTimestamp":1786049853,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings SummaryTectonic Therapeutic IncTECX.OQreported a quarterly adjusted loss of $1.18 per share for the quarter ended June","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433D9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652285","title":"Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652285?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA2ZVNVF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656937379","title":"Tectonic Therapeutic Inc Expected to Post a Loss of $1.35 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656937379","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656937379?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:11","pubTimestamp":1785755466,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc <TECX.OQ> expected to post a loss of $1.35 a share - Earnings PreviewTectonic Therapeutic IncTECX.OQTECX.Ois expected to  show no change in quarterly revenue when it reports  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4400WT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648326521","title":"Tectonic Therapeutic CSO Peter Mcnamara Disposes of USD 6,020 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648326521","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648326521?lang=en_us&edition=fundamental","pubTime":"2026-07-02 05:20","pubTimestamp":1782940827,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic CSO Peter McNamara disposes of USD 6,020 in common sharesTectonic Therapeutic Chief Scientific Officer Peter McNamara exercised employee stock options for 172 shares at $14.71 on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL67MLFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tectonic Therapeutic CSO Peter Mcnamara Disposes of USD 6,020 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647309835","title":"Xeris Names CEO John Shannon Board Chair, Effective July 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647309835","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647309835?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:00","pubTimestamp":1782817219,"startTime":"0","endTime":"0","summary":"Xeris names CEO John Shannon board chair, effective July 1, 2026Xeris Biopharma named CEO John Shannon chair of the board, effective July 1, 2026.Marla Persky stepped down as chair, remaining on the b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL4d2jDk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","TRDA","BK4007","XERS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642791604","title":"Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and Stevanato Group (STVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642791604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642791604?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:20","pubTimestamp":1781126412,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tectonic Therapeutic (TECX) and Stevanato Group (STV...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tectonic-therapeutic-tecx-and-stevanato-group-stvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tectonic-therapeutic-tecx-and-stevanato-group-stvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4539","BK4581","BK4121","XBI","LABU","BK4585","LU0029874061.USD","BK4139","STVN","BK4588","XLV","HCSG","LU0128526141.USD","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642765034","title":"Tectonic Therapeutic files Form 3 for director Jessica Caroline Chutter","url":"https://stock-news.laohu8.com/highlight/detail?id=2642765034","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642765034?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:35","pubTimestamp":1781123741,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic filed an initial statement of beneficial ownership naming Jessica Caroline Chutter as a director on June 10.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tectonic Therapeutic Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL1SShyS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642475658","title":"Tectonic Therapeutic completes enrollment in TX45 APEX Phase 2 trial for PH-HFpEF patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2642475658","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642475658?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:01","pubTimestamp":1781121683,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic completed enrollment in APEX, a Phase 2 trial of TX45 in pulmonary hypertension linked to HFpEF.Topline results have not been presented; readout is expected in early Q1 2027.The study aims to show TX45 can improve disease status in a higher-severity subgroup while supporting an acceptable safety profile.APEX enrolled 191 patients across 14 countries; about 72% were in the enriched CpcPH population.Data from the trial are expected to shape next-step development decisions for TX45 in this indication.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL9hBMsT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014039.USD","BK4588","SG9999014013.SGD","BK4112","LU2095319765.USD","SG9999014005.SGD","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","TECX","LU0314104364.USD","IE00BN0W2V16.EUR","BK4585","IE00BGHQF748.EUR","IE00BN0W2W23.USD","LU2210149790.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642847563","title":"Tectonic Therapeutic - Tx45 Apex Phase 2 Topline Results Expected in Early Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2642847563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642847563?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:01","pubTimestamp":1781121660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA1FN56H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TECX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642475633","title":"Tectonic Therapeutic Completes Enrollment in Tx45 Apex Phase 2 Clinical Trial in Ph-Hfpef Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2642475633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642475633?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:01","pubTimestamp":1781121660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUA1FN56H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636078011","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Tectonic Therapeutic (TECX) and Urogen Pharma (URGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636078011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636078011?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:01","pubTimestamp":1779105697,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tectonic Therapeutic (TECX) and Urogen Pharma (URGN). Tectonic Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-tectonic-therapeutic-tecx-and-urogen-pharma-urgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-tectonic-therapeutic-tecx-and-urogen-pharma-urgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX","BK4588","BK4137","LU0128526141.USD","HCSG","XLV","URGN","LABU","LU0029874061.USD","BK4581","XBI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635523066","title":"LifeSci Capital Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635523066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635523066?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:35","pubTimestamp":1778942135,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Gaurav Maini maintained a Buy rating on Tectonic Therapeutic today and set a price target of $88.00. Maini covers the Healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081485","title":"Oppenheimer Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081485?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:58","pubTimestamp":1778846327,"startTime":"0","endTime":"0","summary":"In a report released today, from Oppenheimer reiterated a Buy rating on Tectonic Therapeutic, with a price target of $80.00. In a report released o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634443493","title":"LifeSci Capital Remains a Buy on Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634443493","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634443493?lang=en_us&edition=fundamental","pubTime":"2026-05-10 10:09","pubTimestamp":1778378989,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Gaurav Maini maintained a Buy rating on Tectonic Therapeutic yesterday and set a price target of $88.00. According to TipRa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633513804","title":"Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633513804","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633513804?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245241,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Tectonic Therapeutic today and set a price target of $76.00. Rahimi covers the Heal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tectonictx.com;investors.tectonictx.com","stockEarnings":[{"period":"1week","weight":-0.0289},{"period":"1month","weight":0.1751},{"period":"3month","weight":0.2079},{"period":"6month","weight":0.5339},{"period":"1year","weight":0.4002},{"period":"ytd","weight":0.7244}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.1168},{"period":"1year","weight":0.1874},{"period":"ytd","weight":0.1234}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.038483},{"month":2,"riseRate":0.5,"avgChangeRate":-0.005058},{"month":3,"riseRate":0.375,"avgChangeRate":-0.012026},{"month":4,"riseRate":0.125,"avgChangeRate":-0.086175},{"month":5,"riseRate":0.75,"avgChangeRate":0.079704},{"month":6,"riseRate":0.25,"avgChangeRate":-0.029433},{"month":7,"riseRate":0.555556,"avgChangeRate":0.096214},{"month":8,"riseRate":0.666667,"avgChangeRate":0.049774},{"month":9,"riseRate":0.375,"avgChangeRate":-0.036701},{"month":10,"riseRate":0.875,"avgChangeRate":0.040067},{"month":11,"riseRate":0.5,"avgChangeRate":0.024692},{"month":12,"riseRate":0.5,"avgChangeRate":-0.049184}],"exchange":"NASDAQ","name":"Tectonic Therapeutic, Inc.","nameEN":"Tectonic Therapeutic, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tectonic Therapeutic, Inc.(TECX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tectonic Therapeutic, Inc.(TECX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tectonic Therapeutic, Inc.,TECX,Tectonic Therapeutic, Inc.股票,Tectonic Therapeutic, Inc.股票老虎,Tectonic Therapeutic, Inc.股票老虎国际,Tectonic Therapeutic, Inc.行情,Tectonic Therapeutic, Inc.股票行情,Tectonic Therapeutic, Inc.股价,Tectonic Therapeutic, Inc.股市,Tectonic Therapeutic, Inc.股票价格,Tectonic Therapeutic, Inc.股票交易,Tectonic Therapeutic, Inc.股票购买,Tectonic Therapeutic, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tectonic Therapeutic, Inc.(TECX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tectonic Therapeutic, Inc.(TECX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction